Gapping down
In reaction to disappointing earnings/guidance:
- AMBA -13.8%, ZUO -13.3%, BIG -9.1%, COO -7.5%, NTNX -6.3%, ULTA -3.9%, YEXT -3.2%, CANG -2.2%
Other news:
- SRC -4.2% (declared quarterly cash dividend of $0.125/share, prior $0.18/share)
- CRON -4.2% (following 25%+ move lower
- SBUX -2.4% (trading lower after Coca-Cola acquired Costa Ltd; speculation of new competition for SBUX)
- CMG -1.8% (Pershing Square lowers active stake)
- AZN -1.7% (announces top-line results from the TULIP 1 Phase III trial for anifrolumab in adult patients with moderate-to-severe systemic lupus erythematosus -- trial did not meet primary endpoint)
Analyst comments:
- ATVI -2.7% (downgraded to Underperform from Neutral at BofA/Merrill)
- GT -2.2% (downgraded to Hold from Buy at Berenberg)